Search

Your search keyword '"Andrisano, V."' showing total 522 results

Search Constraints

Start Over You searched for: Author "Andrisano, V." Remove constraint Author: "Andrisano, V."
522 results on '"Andrisano, V."'

Search Results

103. Acetylcholinesterase Inhibitors:  Synthesis and Structure−Activity Relationships of ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl Derivatives

104. HPLC Determination of Chloramphenicol and Thiamphenicol Residues in Gamebird Meats

117. Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation

118. Protein Flexibility in Virtual Screening: The BACE-1 Case Study

119. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease

120. A small molecule targeting the multifactorial nature of Alzheimer's disease

121. Memoquin: a new therapeutic poly-agent for Alzheimer's disease

122. Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks

123. Investigating in Vitro Amyloid Peptide 1–42 Aggregation: Impact of Higher Molecular Weight Stable Adducts

124. Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease

125. Bio-guided fractionation of stem bark extracts from phyllanthus muellarianus: Identification of phytocomponents with anti-cholinesterase activity

126. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects

127. Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma

128. Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations

129. (±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease

130. Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth

131. Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer

132. Advanced analytical methodologies in Alzheimer's disease drug discovery

133. Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

134. Determination of the dissociation constants (pKa) of basic acetylcholinesterase inhibitors by reversed-phase liquid chromatography

135. Multifunctional activity of some isoquinoline alkaloids from Corydalis cava tubers on Alzheimer's disease targets

136. Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach

137. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

138. Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease

139. Isoquinoline alkaloids from berberis vulgaris as potential lead compounds for the treatment of alzheimer's disease

140. Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma.

141. The role of Chromatography in Alzheimer’s Disease Drug Discovery

142. Amyloid β-Peptide 25–35 Self-Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer’s Disease Process and Treatment

143. Huprine–Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer’s and Prion Diseases

144. Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer’s disease

145. Novel synthesis of physovenine and physostigmine analogs

149. Heterocyclic inhibitors of AChE acylation and peripheral sites

150. Cholinesterase Inhibitors: Xanthostigmine Derivatives Blocking the Acetylcholinesterase-Induced β-Amyloid Aggregation

Catalog

Books, media, physical & digital resources